Lexaptepid Pegol (NOX-H94) in ESA-hyporesponsive Anemia in Dialysis Patients

Clinical trial NCT02079896 · COMPLETED

Trial details

NCT number: NCT02079896
Sponsor: TME Pharma AG
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Anemia End Stage Renal Disease

Start date: 2014-05-01
Primary completion: 2015-11-01
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.